Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease

This study has been completed.
Information provided by (Responsible Party):
TauRx Therapeutics Ltd Identifier:
First received: September 14, 2012
Last updated: June 15, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)